Cargando…

Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

We analysed antibodies specific for human p53 in sera from primary breast cancer patients using three different immunoassays and we related these results to the p53 level in tumour tissue detected by immunohistochemistry. Only 44% (11/25) of apparently enzyme-linked immunosorbent assay (ELISA)-posit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vojtesek, B., Kovarik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., Lane, D. P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033849/ https://www.ncbi.nlm.nih.gov/pubmed/7779720

Ejemplares similares

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
por: Speiser, P., et al.
Publicado: (1996)

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.
por: Vojtĕsek, B., et al.
Publicado: (1993)

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
por: Regele, S, et al.
Publicado: (1999)

The relationship between serum p53 autoantibodies and characteristics of human breast cancer.
por: Mudenda, B., et al.
Publicado: (1994)

Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative Breast Cancer
por: Stenckova, Michaela, et al.
Publicado: (2022)

Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
por: Hrstka, Roman, et al.
Publicado: (2009)

P53 autoantibodies in 1006 patients followed up for breast cancer
por: Metcalfe, Su, et al.
Publicado: (2000)

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997)

Drugging in the absence of p53
por: Aning, Obed Akwasi, et al.
Publicado: (2019)

Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer
por: Ruckova, Eva, et al.
Publicado: (2012)

p53 isoforms regulate premature aging in human cells
por: von Muhlinen, Natalia, et al.
Publicado: (2018)

The Clinical Significance of Autoantibody Detection
por: Goudie, R. B.
Publicado: (1970)

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001)

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.
por: Fisher, C. J., et al.
Publicado: (1994)

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.
por: Bártek, J., et al.
Publicado: (1987)

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
por: Bourdon, Jean-Christophe, et al.
Publicado: (2011)

Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.
por: Joypaul, B. V., et al.
Publicado: (1994)

Prognostic significance of TP53 alterations in breast carcinoma.
por: Andersen, T. I., et al.
Publicado: (1993)

Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
por: Brozkova, Kristyna, et al.
Publicado: (2008)

Updates on p53: modulation of p53 degradation as a therapeutic approach
por: Dey, A, et al.
Publicado: (2008)

Delay in development and behavioural abnormalities in the absence of p53 in zebrafish
por: Elabd, Seham, et al.
Publicado: (2019)

Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
por: Obacz, Joanna, et al.
Publicado: (2013)

Absence of p53 in Clara cells favours multinucleation and loss of cell cycle arrest
por: Armit, Christopher J, et al.
Publicado: (2002)

Detection and Quantification of Tp53 and p53-Anti-p53 Autoantibody Immune Complex: Promising Biomarkers in Early Stage Lung Cancer Diagnosis
por: Song, Keum-Soo, et al.
Publicado: (2022)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression
por: Abubakar, Mustapha, et al.
Publicado: (2019)

Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
por: Smith, D. R., et al.
Publicado: (1996)

Bax/Bak activation in the absence of Bid, Bim, Puma, and p53
por: Zhang, J, et al.
Publicado: (2016)

p53 accumulation following cytokinesis failure in the absence of caspase-2
por: Lim, Yoon, et al.
Publicado: (2018)

p53-mediated neurodegeneration in the absence of the nuclear protein Akirin2
por: Peek, Stacey L., et al.
Publicado: (2022)

Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence
por: Rana, Manjit K, et al.
Publicado: (2021)

Switching p53-dependent growth arrest to apoptosis via the inhibition of DNA damage-activated kinases
por: Hublarova, Pavla, et al.
Publicado: (2010)

p53 in colorectal cancer: clinicopathological correlation and prognostic significance.
por: Scott, N., et al.
Publicado: (1991)

Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients
por: Cressey, Ratchada, et al.
Publicado: (2008)

∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem‐like cells in human ER(+) and HER2(+) breast cancers
por: Liu, Yajing, et al.
Publicado: (2019)

Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53
por: Li, Frank Q., et al.
Publicado: (2007)

Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
por: Nagai, M. A., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_e62r35dosgsuhnlmebnitb0t33